If PFE were going to acquire MYOV, they presumably would've done it two days ago, when the Orgovyx collaboration was announced. Sumitomo (a/k/a Millennium Pharmaceuticals) could yet make a move. p.s. MYOV is a popular choice in the 2021 charity contest on Silicon Investor.